Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | Y1A201M | OT |
accidentally administered 0.1 ml of IPV instead of a PPD skin test to a baby, with no reported adverse event; Initial information received on 10-Mar-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 months old female patient who experienced accidentally administered IPV (VERO) [IPOL] 0.1 ml of ipv instead of a tuberculin test [Tuberculin Ppd] to a baby,with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Measles vaccine, Mumps vaccine, Rubella vaccine (Mmr) for Immunisation; Varicella zoster vaccine for Immunisation; Hepatitis a vaccine for Immunisation; and Influenza vaccine for Immunisation. On 05-Mar-2025, the patient accidentally received 0.1 ml of suspect IPV (VERO),Suspension for injection, lot Y1A201M, strength: standard, frequency: once, Expiry date:31-Jan-2027 via unknown route in unknown administration site for Immunization instead of a tuberculin test with no reported adverse event (wrong product administered) (latency: same day). Reportedly,verified that ipv's brand name is ipo. Action taken not applicable This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
MMRVAXPRO; Hepatitis A; Influenza vaccine